Figure 2From: Varied spectrum of clinical presentation and mortality in a prospective registry of visceral leishmaniasis in a low endemicity area of Northern Italy Kaplan-Meyer analysis of Relapse-free time after the first Visceral Leishmaniasis event among observed patients. Panel A. Time to relapse (in days) in Immunocompetent(ICC)vs. Immunocompromised (ISS) pts. Log-rank test for equality of survivor functions (chi2 = 0.0002); Wilcoxon (Breslow) test for equality of survivor functions (Pr > chi2 =0.0004). Panel B. Time to relapse (in days) in Immunesuppresed pts.: HIV + vs. other causes (Others). Log-rank test for equality of survivor functions (chi2 = n.s.); Wilcoxon (Breslow) test for equality of survivor functions (Pr > chi2 = n.s.).Back to article page